Fedratinib, sold under the brand name Inrebic, is an anti-cancer medication used to treat myeloproliferative diseases including myelofibrosis. Reference standards of Fedratinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Fedratinib
Catalogue No.:PA 06 2020000
CAS :
Molecular Formula : C27H36N6O3S
Molecular Weight : 524.68
4-(2-(pyrrolidin-1-yl)ethoxy)aniline
Catalogue No.:PA 06 2021000
Molecular Formula : C12H18N2O
Molecular Weight : 206.29
N-(Tert-butyl)-3-((2-chloro-5-methylpyrimidin-4-yl)amino)benzenesulfonamide
Catalogue No.:PA 06 2021001
Molecular Formula : C15H19ClN4O2S
Molecular Weight : 354.85
3-((5-methyl-2-((4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide
Catalogue No.:PA 06 2021002
Molecular Formula : C23H28N6O3S
Molecular Weight : 468.58
Fedratinib D9
Catalogue No.:PA STI 089367
Molecular Formula : C27H27D9N6O3S
Molecular Weight : 533.74
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
